Krida Jaringan Nusantara Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Krida Jaringan Nusantara Tbk trades at Rp152 (market cap 80B, 8.55M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.1× Krida Jaringan Nusantara Tbk's market cap, and Krida Jaringan Nusantara Tbk is more actively traded (8.55M versus 324K). Which is the better fit depends on your goals.
| KJEN | OBAT | |
|---|---|---|
Market Cap | 80B | 166.01B |
Volume | 8.55M | 324K |
Lot | 85.45K | 3.24K |
Turnover | 1.29B | 77.68M |
Average Price | 150.69 | 239.75 |
Value | 1.29B | 77.68M |
Indicative Equilibrium Price | 152 | 240 |
Indicative Equilibrium Volume | 1.33K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Krida Jaringan Nusantara Tbk (the Company) was established in Jakarta based on the NotarialDeed No. 5 dated October 1, 1998 of Saal Bumela, S.H., Notary in Jakarta.
Read more on KJEN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →